News & Updates

Continued treatment with tumor necrosis factor (TNF) inhibitors after 24 weeks of pregnancy appears safe and is associated with lower chances of maternal inflammatory bowel disease (IBD) relapse, without increasing adverse neonatal outcomes, new research suggests.

Using a lower glycaemic threshold led to more diagnoses of gestational diabetes, though its impact on maternal and birth outcomes remains uncertain, results of the GEMS* trial showed.

Among individuals carrying the 17q12-21 asthma-risk variant rs2305480, owning a dog appears to exert a protective effect against persistent wheeze, a recent study has found.

Predicting which newborn will go on to develop atopic dermatitis (AD) and how severe it will be is now feasible, according to the BABY* study.